Last reviewed · How we verify
NCT07356401
Associations of Cranial Outcomes and Parental Expectations and Satisfaction
trial testing Cranial orthosis in Plagiocephaly in 20 participants. Currently enrolling.
15 February 2026
Quick facts
| Lead sponsor | Gulhane School of Medicine |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 25 November 2025 |
| Primary completion | 15 February 2026 |
| Estimated completion | 15 March 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Cranial orthosis
Conditions studied
- Plagiocephaly — all drugs for Plagiocephaly →
- Cranial Defect — all drugs for Cranial Defect →
- Orthosis — all drugs for Orthosis →
- Expectancy — all drugs for Expectancy →
Sponsor
Gulhane School of Medicine
Who can join
Adults 3 Months to 18 Months, any sex, with Plagiocephaly or Cranial Defect. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the association between objective cranial morphological changes and parental expectations and satisfaction in infants undergoing treatment with a cranial remolding orthosis (CRO). Infants diagnosed with positional cranial deformities and prescribed CRO treatment will be included. Cranial morphological outcomes will be assessed using standardized cranial measurements obtained before and after the treatment period. Parental treatment expectations will be evaluated prior to the initiation of CRO therapy using the Treatment Expectation Questionnaire (TR.TEX-Q), while parental satisfaction with the device and treatment process will be assessed at the end of treatment using the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST). The primary objective of the study is to examine the relationships between changes in cranial morphology and parental expectations and satisfaction scores. Secondary objectives include exploring the association between baseline expectations and post-treatment satisfaction. The findings are expected to provide insight into how objective treatment outcomes align with family-reported perceptions in cranial remolding orthosis therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07356401
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Plagiocephaly
Currently open trials in the same condition.
- NCT06425172 — Monitoring System for Cranial Orthoses · recruiting
Other Gulhane School of Medicine trials
Trials by the same sponsor.
- NCT07383987 — Genital Hygiene, Toilet Behaviors, and LUTS in Normal Weight and Obese Women · recruiting
- NCT07374237 — Evaluation of Interoception, Fatigue, and Upper and Lower Extremity Functional Capacity in Multiple Sclerosis Patients W · completed
- NCT07347561 — A Comparison of Myoelectric and Bionic Hands · recruiting
- NCT06850428 — Examining the Relationship Between Physical Activity Levels and Chronotype Tendencies in Individuals With Alcohol Depend · recruiting
- NCT06879392 — Examination of Physiotherapists' Knowledge, Awareness and Competence on Physical Activity and Exercise in Hemophilia Pat · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07356401 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gulhane School of Medicine
- Last refreshed: 26 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07356401.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing